Search

Search Constraints

You searched for: Author/Creator Papadavid, Evangelina

Search Results

1. An update on health-related quality of life from the PROCLIPI study. (October 2021)

2. Defining B2 involvement in Sezary syndrome results from the PROCLIPI study. (2019)

3. Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb–IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT). (October 2021)

4. Prognostic factors in mycosis fungoides: the PROCLIPI study. (2019)

5. Quality of life in patients with mycosis fungoides and Sezary syndrome is significantly worse in female patients, Sézary syndrome and those with more extensive skin involvement. (September 2018)

6. Treatment of early-phase mycosis fungoides: results from the Prospective Cutaneous Lymphoma International (PROCLIPI) study. (2019)